A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 26
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : BP
Long Form : biodegradable polymer
No. Year Title Co-occurring Abbreviation
2021 Assessment of utility values and QALYs after primary PCI with DP-Xience and BP-Biomatrix stents. DES, DP, HRQoL, PPCI, QALY, QoL, STEMI, VAS
2020 Biodegradable polymer-coated versus durable polymer-coated sirolimus-eluting stents: the final 5-year outcomes of the I-LOVE-IT 2 trial. CI, DAPT, DP, HR, MI, SES, ST, TLF
2020 Comparison of Durable-Polymer- and Biodegradable-Polymer-Based Newer-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes After Successful Percutaneous Coronary Intervention. aHR, AMI, BES, CI, DESs, DP, EES, MACEs, PCI, re-MI, ST, TLR, TVR, ZES
2019 One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI. BES, DES, DP, HR, MACE, MVD, PCI, re-MI, ST, STEMI
2019 Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort. SESs, ST, TLF
2018 Biodegradable-Polymer Versus Polymer-Free Drug-Eluting Stents for the Treatment of Coronary Artery Disease. DES, DP, LLL, MI, PF, ST, TLR, TVR
2018 Impact of current smoking on 2-year clinical outcomes between durable-polymer-coated stents and biodegradable-polymer-coated stents in acute myocardial infarction after successful percutaneous coronary intervention: Data from the KAMIR. AMI, BES, CD, CI, DES, DP, EES, HR, MACE, PCI, re-MI, ST, TLR, TVR, ZES
2018 Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography. APSM, ASM, BES, DES, LASM, LSM, PP
2018 Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents. DES, DP, NA, OCT
10  2018 The comparison of early healing 1-month after PCI among CoCr-everolimus-eluting stent (EES), biodegradable polymer (BP)-EES and BP-sirolimus-eluting stent: Insights from OFDI and coronary angioscopy. CAS, Co-Cr, EES, OFDI, PLIA, SC, SES, YC
11  2018 Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR. AMI, BES, CD, CI, DES, DP, EES, HR, MACE, MI, PCI, ST, TD, TLR, TVR, ZES
12  2017 Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial. AMI, DES, MI, POCE, ST, TLF
13  2017 Enzymatic degradation of poly-butylene succinate-co-adipate film in rice husks by yeast Pseudozyma antarctica in indoor conditions. PBSA
14  2017 Polymer-Free Drug-Coated Coronary Stents in Patients with Stable Coronary Artery Disease at High Bleeding Risk. BMS, CAD, DAPT, DES, PCI, PF-DCS, PP, RCTs
15  2017 Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging. DES, DP, EES, OFDI
16  2016 Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents. DP, EES, MI, SES, TLF
17  2016 Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds: Evidence From a Network Meta-Analysis of 147 Trials. BMS, BP-BES, BVS, Co-Cr, DES, E-ZES, EES, PES, PtCr, R-ZES, SES
18  2016 Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR). AMI, DES, DP, KAMIR, MACE, re-MI, ST, TVR
19  2015 Biolimus-Eluting StenT For de-novo coRonary artery dIsease in patiENts with Diabetes mellituS: the BESTFRIENDS multicentre registry. bp-BES, PCI, TLR
20  2015 Four-year clinical follow-up of the first-in-man randomized comparison of a novel sirolimus eluting stent with abluminal biodegradable polymer and ultra-thin strut cobalt-chromium alloy: the INSPIRON-I trial. MACE, MI, SES, ST, TLR, TVR
21  2015 Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial. BMS, DES, MACE, MI, PES, SES, ST, TVR
22  2014 Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. BMS, BP-BES, CoCr-EES, CrI, DES, PtCr-EES, SES, ST, ZES-R
23  2014 Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials. DP-DES, DP-SES, HR, STEMI, TLR
24  2011 Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents. PP
25  2009 Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results. DES, LLL, MI, PF, PP, TLR
26  2008 Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. PF, PP